Mereo BioPharma (MREO) Return on Equity [ROE] (2023 - 2026)
Mereo BioPharma (MREO) reported Return on Equity [ROE] of -89.62% for Q2 2026, down 2.89 percentage points from -86.73% a year earlier but up 5.64 percentage points from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Mereo BioPharma posted Return on Equity [ROE] of -82.21%, down 4.63 percentage points from FY2024.
- Return on Equity [ROE] has declined for four consecutive years, though with a five-year change of +1268.62 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -77.58% in FY2024 (-19.77 pp), -57.81% in FY2023 (-10.63 pp), -47.18% in FY2022 (-81.88 pp) and 34.70% in FY2021 (+1385.53 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -1482.37% in Q3 2024 and a high of -56.00% in Q4 2023.
- Year over year, Return on Equity [ROE] gained in 1 of the last five quarters, with an average year-over-year change of +266.41 percentage points.
- Per Business Quant data, the three quarters before Q2 2026 came in at -95.26% (Q1 2026), -95.71% (Q4 2025) and -82.51% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Mereo BioPharma | 47.91 Mn | -79.40 Mn | 800,000.00 | -108.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -108.09% |
| Jun 30, 2026 | -101.24% |
| Mar 31, 2026 | -88.01% |
| Dec 31, 2025 | -77.36% |
| Sep 30, 2025 | -82.12% |
| Jun 30, 2025 | -69.87% |
| Mar 31, 2025 | -73.02% |
| Sep 30, 2024 | -1,139.42% |
| Jun 30, 2024 | -61.10% |
| Mar 31, 2024 | -54.01% |
| Dec 31, 2023 | -48.01% |
API Access
Mereo BioPharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();